Page 9 - Flipbook

ERSPC (European Randomized Study of Screening for

Prostate Cancer)

• 162 243 men aged 55 to 69 years

• PSA screening once q1-4 years or an unscreened control group

• Median f/u 11 years

• The cumulative incidence of PCa was 8.2% in the screened group

vs 4.8%

• PCa death was reduced by 21% and 29% after adjustment for

noncompliance

• 9 years (Numbers Needed to Screen 1410, Numbers Needed to

Diagnose 48)

Lancet. 2014 Dec 6; 384(9959): 2027–2035.